GAMMA Investing’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Sell
1,686
-220
-12% -$18.6K ﹤0.01% 1728
2026
Q1
$189K Buy
1,906
+15
+0.8% +$1.96K 0.01% 1162
2025
Q4
$230K Buy
1,891
+45
+2% +$5.65K 0.01% 939
2025
Q3
$207K Sell
1,846
-36
-2% -$4.21K 0.01% 960
2025
Q2
$252K Buy
1,882
+318
+20% +$34.9K 0.02% 765
2025
Q1
$105K Buy
1,564
+1,324
+552% +$91.1K 0.01% 1210
2024
Q4
$15K Buy
240
+57
+31% +$5.31K ﹤0.01% 2415
2024
Q3
$28.7K Buy
183
+41
+29% +$6.32K ﹤0.01% 1882
2024
Q2
$21.4K Buy
142
+25
+21% +$3K ﹤0.01% 1811
2024
Q1
$8.65K Buy
117
+31
+36% +$2.56K ﹤0.01% 2139
2023
Q4
$7.38K Buy
+86
New +$5.19K ﹤0.01% 2056

Other funds holding TMDX

GAMMA Investing's TMDX Position: Q2 2026 in Review

GAMMA Investing reduced its Transmedics (TMDX) stake by 12% in Q2 2026, selling an estimated $18.6K and leaving 1,686 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

GAMMA Investing first reported a position in TMDX in Q4 2023 and has held it in 11 quarters since. The position peaked at $252K in Q2 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • GAMMA Investing held 1,686 shares of Transmedics worth $112K as of Q2 2026.
  • GAMMA Investing sold 220 Transmedics shares in Q2 2026, an estimated $18.6K.
  • Transmedics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1728 holding.
  • GAMMA Investing first reported a position in Transmedics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Transmedics position peaked at $252K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.